PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
NOVO-B.CO vs. EPHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

NOVO-B.CO vs. EPHE

Last updated Jun 13, 2026

NOVO-B.CO (Novo Nordisk A/S) is a stock, while EPHE (iShares MSCI Philippines ETF) is Asia Pacific Equities fund tracking the MSCI Philippines Investable Market Index. Over the past 10 years, NOVO-B.CO returned 17.36%/yr vs -3.07%/yr for EPHE. At a 0.13 correlation, their price movements are largely independent.

Performance

NOVO-B.CO vs. EPHE - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novo Nordisk A/S (NOVO-B.CO) and iShares MSCI Philippines ETF (EPHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NOVO-B.CO is traded in DKK, while EPHE is traded in USD. To make them comparable, the EPHE values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVO-B.CO achieves a -8.64% return, which is significantly lower than EPHE's 1.94% return. Over the past 10 years, NOVO-B.CO has outperformed EPHE with an annualized return of 17.36%, while EPHE has yielded a comparatively lower -3.07% annualized return.

NOVO-B.CO

1D
1.66%
1M
-3.99%
YTD
-8.64%
6M
-7.47%
1Y
-41.76%
3Y*
4.58%
5Y*
20.64%
10Y*
17.36%

EPHE

1D
1.07%
1M
1.71%
YTD
1.94%
6M
2.79%
1Y
-7.72%
3Y*
-1.30%
5Y*
-2.03%
10Y*
-3.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVO-B.CO vs. EPHE - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
NOVO-B.CO
Novo Nordisk A/S		-8.64%-46.40%-9.59%205.34%31.49%79.08%15.29%36.17%-6.15%39.57%
EPHE
iShares MSCI Philippines ETF		1.94%-10.34%5.14%-1.52%-10.62%4.93%-12.21%11.03%-13.41%5.53%

Correlation

The correlation between NOVO-B.CO and EPHE is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Sep 29, 2010

0.13

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Novo Nordisk A/S

iShares MSCI Philippines ETF

Often compared with NOVO-B.CO:
NOVO-B.CO vs. SPYNOVO-B.CO vs. LLYNOVO-B.CO vs. QQQNOVO-B.CO vs. NOV.DENOVO-B.CO vs. SAABYNOVO-B.CO vs. LLY.DENOVO-B.CO vs. MONC.MI
Often compared with EPHE:
EPHE vs. VOOEPHE vs. EWYEPHE vs. EIDOEPHE vs. VTEPHE vs. VTIEPHE vs. VXUSEPHE vs. GOVT

Return for Risk

NOVO-B.CO vs. EPHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
NOVO-B.CO
NOVO-B.CO Risk / Return Rank: 1313
Overall Rank
NOVO-B.CO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NOVO-B.CO Sortino Ratio Rank: 1414
Sortino Ratio Rank
NOVO-B.CO Omega Ratio Rank: 1212
Omega Ratio Rank
NOVO-B.CO Calmar Ratio Rank: 1313
Calmar Ratio Rank
NOVO-B.CO Martin Ratio Rank: 1717
Martin Ratio Rank
EPHE
EPHE Risk / Return Rank: 55
Overall Rank
EPHE Sharpe Ratio Rank: 55
Sharpe Ratio Rank
EPHE Sortino Ratio Rank: 55
Sortino Ratio Rank
EPHE Omega Ratio Rank: 55
Omega Ratio Rank
EPHE Calmar Ratio Rank: 55
Calmar Ratio Rank
EPHE Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVO-B.CO vs. EPHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and iShares MSCI Philippines ETF (EPHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

NOVO-B.COEPHEDifference
Sharpe ratioReturn per unit of total volatility
-0.78
-0.48

-0.31

Sortino ratioReturn per unit of downside risk
-0.91
-0.58

-0.33

Omega ratioGain probability vs. loss probability

0.87

0.94

-0.07

Calmar ratioReturn relative to maximum drawdown

-0.78

-0.58

-0.20

Martin ratioReturn relative to average drawdown

-1.15

-1.05

-0.10

NOVO-B.CO vs. EPHE - Sharpe Ratio Comparison

The current NOVO-B.CO Sharpe Ratio is -0.78, which is lower than the EPHE Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of NOVO-B.CO and EPHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

NOVO-B.CO vs. EPHE - Drawdown Comparison

The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than EPHE's maximum drawdown of -55.15%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and EPHE.

Loading charts...

Drawdown Indicators

NOVO-B.COEPHEDifference

Max Drawdown

Largest peak-to-trough decline

-76.75%

-55.15%

-21.60%

Max Drawdown (1Y)

Largest decline over 1 year

-54.63%

-15.23%

-39.40%

Max Drawdown (3Y)

Largest decline over 3 years

-76.75%

-24.19%

-52.56%

Max Drawdown (5Y)

Largest decline over 5 years

-76.75%

-26.43%

-50.32%

Max Drawdown (10Y)

Largest decline over 10 years

-76.75%

-51.00%

-25.75%

Current Drawdown

Current decline from peak

-70.15%

-39.20%

-30.95%

Average Drawdown

Average peak-to-trough decline

-11.29%

-24.07%

+12.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.11%

9.10%

+28.01%

Volatility

NOVO-B.CO vs. EPHE - Volatility Comparison

Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.47% compared to iShares MSCI Philippines ETF (EPHE) at 4.77%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than EPHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

NOVO-B.COEPHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.47%

4.77%

+6.70%

Volatility (6M)

Calculated over the trailing 6-month period

39.57%

13.35%

+26.22%

Volatility (1Y)

Calculated over the trailing 1-year period

54.40%

18.63%

+35.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.56%

17.62%

+40.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.08%

22.25%

+22.83%

Dividends

NOVO-B.CO vs. EPHE - Dividend Comparison

NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%, more than EPHE's 2.10% yield.

PositionTTM20252024202320222021202020192018201720162015
EPHE
iShares MSCI Philippines ETF		2.10%2.11%2.32%2.01%1.73%1.05%0.72%0.78%0.45%0.36%0.71%1.03%
NOVO-B.CO
Novo Nordisk A/S		4.07%3.58%1.59%1.01%2.38%2.54%4.03%4.22%5.27%4.54%7.38%2.50%

Frequently Asked Questions

NOVO-B.CO and EPHE have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NOVO-B.CO and EPHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer